Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Ann Surg Oncol. 2012 May 31;19(8):2547–2555. doi: 10.1245/s10434-012-2398-z

Figure 1.

Figure 1

Figure 1

Figure 1A. Overall survival for patients whose recurrent stage IV melanoma was treated with surgery ± SMT (n=161, median survival 15.8 months, 4-year survival 20.8%) versus systemic medical therapy alone (n=130, median survival 6.9 months, 4-year survival 7.0%).

Figure 1B. Overall survival for patients by treatment received: surgery only (n=43, median survival 22.1 months, 4-year survival 45.7%), systemic medical therapy followed by surgery (n=33, median survival 17.1 months, 4-year survival 18.2%), surgery followed by systemic medical therapy (n=85, median survival 14.7 months, 4-year survival 12.3%), or systemic medical therapy alone (n=130, median survival 6.9 months, 4-year survival 7.0%). P value <0.0001.